A	B	C
1	Main
2		Brand Name	Promacta (US), Revolade (EU)
3		Generic Name	eltrombopag
4		Indication	ITP
5		Mechanism	oral platelet growth factor
6		Competition	Nplate (AMG531, Amgen). May have more durable responses than Nplate.
7		Approval	10/10 Japan approval.
8			3/12/10 EU approval.
9			12/18/09 EMEA positive opinion.
10		Clinical Trials	p2 data 6/19/06 shows 81% of patients achieving primary endpoint (>50k/micro liter after up to 6wks) vs 11% for placebo after "up to 6 weeks" of dosing
11			data presented at EHA
12			ASCO 2006
13			oral platelet growth factor increases platelet counts in thrombocytopenic patients and healthy subjects